EULAR 2025 | CASE REPORTS
Case Reports are individual or small scale records of a specific disease, treatment, or process which may hold particular value to the medical community. Case Reports do not follow the same rigorous processes of hypothesis-drive research, and are considered anecdotal, but can provide valuable information on rare diseases as well unusual presentations of common diseases, or innovative ways of treating disease.
If your case report is novel, unusual, or has a very specific learned lesson, with proof of the hypothesis, we welcome the submission of your abstract in the appropriate topic within the Case Report track.
TOPICS
- Antiphospholipid syndrome
- Autoinflammatory disease, VEXAS and other monogenic diseases
- Behcet's disease
- Crystal related disorders
- Immunodeficiency
- Infection
- Infection-related rheumatic diseases
- Inflammatory arthritis
- Inflammatory myopathies
- Juvenile idiopathic arthritis
- Metabolic bone diseases and osteoporosis
- Mixed connective tissue disease
- Osteoarthritis and other mechanical musculoskeletal problems
- Other connective tissue diseases
- Pain in rheumatic diseases, including fibromyalgia
- Psoriatic arthritis
- Public and global health
- Rheumatoid arthritis
- Sarcoidosis
- Sjögren's syndrome
- Spondyloarthritis
- Systemic lupus erythematosus
- Systemic sclerosis
- Vasculitis, small and medium size vessels
- Vasculitis, large vessels including polymyalgia rheumatica
- Across diseases
- Other diseases
- Other topics
KEYWORDS
Adaptive immunity; Animal Models; Anti-Inflammatory Agents, Non-Steroidal; Artificial Intelligence; Atherosclerosis; Autoantibodies; biological DMARD; Biomarkers; Biosimilar Pharmaceuticals; Bone; Cardiovascular system; Cartilage; Clinical Trial; Cognitive Function and Mental Health; Comorbidities; Cytokines and Chemokines; Descriptive Studies; Diagnostic test; Diet and Nutrition; Disease-modifying Drugs (DMARDs); Diversity, Equity, and Inclusion (DEI); Economics; Education; Enteritis; Epidemiology; Epitranscriptomics, epigenetics, and genetics; Fatigue; Fibroblasts; Gastrointestinal tract; Geographical differences; Global Health; Glucocorticoids; Health services research; Imaging; Infection; Innate immunity; Interdisciplinary research; Lifestyles; Lungs; Magnetic Resonance Imaging; Microbiome; Non-pharmacological interventions; Nursing; Observational studies/registry; Occupational therapy; -omics; Oncology; Outcome measures; Pain; Patient organisations; Patient Reported Outcome Measures; Patient-led research; Physical therapy, Physiotherapy, and Physical Activity; Pregnancy and reproduction; Prognostic factors; Public health; Qualitative research; Quality of care; Quality of life; Randomised controlled trial; Rare/orphan diseases; Real-world evidence; Registries; Rehabilitation; Remission; Renal System; Safety; Sarcopenia; Self-management; Skin; Social work; Synovium; Systematic review; Tapering; Targeted synthetic drugs; Telemedicine, digital health, and measuring health; Ultrasound; Uveitis; Vaccination/Immunisation; Validation; Work-related issues
FORMAT AND LENGTH
It is mandatory to use the Case Report template provided by the system. Please read all instructions carefully before preparing your abstract.
Counting towards the 2500 characters for Case Reports:
- Abstract title (minimum 15, maximum 300 characters)
- Headings and content of the case report, structured into the following sections:
- Background
- Case presentation
- Learning points for clinical practice
- References (optional)
Characters not counted, but part of final abstract:
- Author first names, middle initials and last names
- Author affiliations
- Acknowledgements including working group
- Working group + "on behalf of" if entered
- Abstract number
- DOI (Declaration of conflict of interest)
- Invisible characters such as spaces
Table and figures:
A total maximum of one figure, graph, image or table is allowed per case report. Multi-panel figures are allowed.
Tables should not have more than 12 columns or 20 rows. Tables turned into pictures/images are accepted, they but should have sufficient quality that everything is readable. Data in images cannot be edited after the abstract has been accepted.
Abstracts can be re-edited and modified until the submission deadline. After the submission deadline, NO modification will be accepted by the EULAR team.